Compare Cadila Healthcare with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TORRENT PHARMA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE TORRENT PHARMA CADILA HEALTHCARE/
TORRENT PHARMA
 
P/E (TTM) x 20.0 62.2 32.2% View Chart
P/BV x 2.7 7.3 36.7% View Chart
Dividend Yield % 1.3 0.8 154.2%  

Financials

 CADILA HEALTHCARE   TORRENT PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
TORRENT PHARMA
Mar-19
CADILA HEALTHCARE/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs4321,964 22.0%   
Low Rs3061,245 24.6%   
Sales per share (Unadj.) Rs128.6453.4 28.4%  
Earnings per share (Unadj.) Rs18.525.8 71.9%  
Cash flow per share (Unadj.) Rs24.462.3 39.2%  
Dividends per share (Unadj.) Rs3.5017.00 20.6%  
Dividend yield (eoy) %0.91.1 89.4%  
Book value per share (Unadj.) Rs101.5279.2 36.3%  
Shares outstanding (eoy) m1,023.74169.22 605.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.93.5 81.2%   
Avg P/E ratio x19.962.2 32.0%  
P/CF ratio (eoy) x15.125.8 58.8%  
Price / Book Value ratio x3.65.7 63.4%  
Dividend payout %18.965.9 28.6%   
Avg Mkt Cap Rs m378,170271,513 139.3%   
No. of employees `00012.413.6 91.5%   
Total wages/salary Rs m21,24114,038 151.3%   
Avg. sales/employee Rs Th10,585.05,642.6 187.6%   
Avg. wages/employee Rs Th1,707.81,032.4 165.4%   
Avg. net profit/employee Rs Th1,526.5320.9 475.8%   
INCOME DATA
Net Sales Rs m131,65676,728 171.6%  
Other income Rs m2,011571 352.5%   
Total revenues Rs m133,66777,299 172.9%   
Gross profit Rs m29,73119,831 149.9%  
Depreciation Rs m5,9866,177 96.9%   
Interest Rs m1,9355,038 38.4%   
Profit before tax Rs m23,8219,187 259.3%   
Minority Interest Rs m4690-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-3,570 0.0%   
Tax Rs m5,3031,254 423.1%   
Profit after tax Rs m18,9874,363 435.2%  
Gross profit margin %22.625.8 87.4%  
Effective tax rate %22.313.6 163.2%   
Net profit margin %14.45.7 253.6%  
BALANCE SHEET DATA
Current assets Rs m84,98150,375 168.7%   
Current liabilities Rs m73,42551,653 142.1%   
Net working cap to sales %8.8-1.7 -527.1%  
Current ratio x1.21.0 118.7%  
Inventory Days Days7592 81.0%  
Debtors Days Days11068 160.4%  
Net fixed assets Rs m133,49383,648 159.6%   
Share capital Rs m1,024846 121.0%   
"Free" reserves Rs m102,83946,397 221.6%   
Net worth Rs m103,86347,244 219.8%   
Long term debt Rs m39,49739,129 100.9%   
Total assets Rs m234,831141,209 166.3%  
Interest coverage x13.32.8 471.4%   
Debt to equity ratio x0.40.8 45.9%  
Sales to assets ratio x0.60.5 103.2%   
Return on assets %8.96.7 133.8%  
Return on equity %18.39.2 197.9%  
Return on capital %18.312.3 148.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m48,40422,103 219.0%   
Fx outflow Rs m11,5935,522 210.0%   
Net fx Rs m36,81116,581 222.0%   
CASH FLOW
From Operations Rs m28,82317,981 160.3%  
From Investments Rs m-57,387-2,413 2,378.4%  
From Financial Activity Rs m18,846-13,145 -143.4%  
Net Cashflow Rs m-7,1052,380 -298.5%  

Share Holding

Indian Promoters % 74.8 71.5 104.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 7.0 118.2%  
FIIs % 5.9 12.6 46.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 8.8 125.0%  
Shareholders   44,069 26,511 166.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ABBOTT INDIA  NATCO PHARMA  DIVIS LABORATORIES  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Buzz on the Street: A Look at Stocks, Sectors and the Economy(Podcast)

The stock markets in India remained rangebound this week. Economic data releases and third quarter results announcements were the focus of the week.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 36.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 36.3% YoY). Sales on the other hand came in at Rs 20 bn (up 5.9% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 32.5% (Quarterly Result Update)

Jul 25, 2019 | Updated on Jul 25, 2019

For the quarter ended June 2019, TORRENT PHARMA has posted a net profit of Rs 2 bn (up 32.5% YoY). Sales on the other hand came in at Rs 20 bn (up 8.0% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

Bet on These Smallcap Stocks for Success in 2020(Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex(Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

How to Buy the Best Safe Stocks in 2020(The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market(Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys(The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 24, 2020 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS